Key Genomic Alterations in Cutaneous T-Cell Lymphoma Less Oncology Times. 44(8):1,23, April 20, 2022. Favorites PDF Get Content & Permissions Free
HIV Not Likely to Result in T-Cell Lymphoma Nolen, Lindsey Nolen, Lindsey Less Oncology Times. 43(24):1,19, December 20, 2021. Favorites PDF Get Content & Permissions Free
Umbralisib (Ukoniq™) Lovell, Alexandra Lovell, Alexandra Less Oncology Times. 43(21):13, November 5, 2021. Favorites PDF Get Content & Permissions Free
Advances in Off-the-Shelf Immunotherapy: Expert Discussion Kumar Das, Dibash Kumar Das, Dibash Less Oncology Times. 43(19):12-13, October 5, 2021. Favorites PDF Get Content & Permissions Free CME Test
CAR T-Cell Therapy Emerges as Option in Follicular Lymphoma Schneider, Mary Ellen Schneider, Mary Ellen Less Oncology Times. 43(18):1,8, September 20, 2021. Favorites PDF Get Content & Permissions Free
Subcutaneous Epcoritamab for B-Cell Non-Hodgkin Lymphoma Nalley, Catlin Nalley, Catlin Less Oncology Times. 43(17):28, September 5, 2021. Favorites PDF Get Content & Permissions Free
Blood Cancer Patients With COVID-19 Fare Better With Convalescent Plasma Less Oncology Times. 43(13):1,12, July 5, 2021. Favorites PDF Get Content & Permissions Free
Protein Found to Control Drivers of Normal Growth & Cancer Less Oncology Times. 43(12):1,13, June 20, 2021. Favorites PDF Get Content & Permissions Free
Copanlisib Combination Cuts Lymphoma Progression by Nearly Half Samson, Kurt Samson, Kurt Less Oncology Times. 43(10):1,18, May 20, 2021. Favorites PDF Get Content & Permissions Free
New CAR-T Approach Minimizes Resistance in B-Cell Lymphoma Less Oncology Times. 43(9):1,21, May 5, 2021. Favorites PDF Get Content & Permissions Free
Peripheral T-Cell Lymphoma: Treatment & Stratification of Risk & Prognosis Simoneaux, Richard Simoneaux, Richard Less Oncology Times. 43(8):1,13-14, April 20, 2021. Favorites PDF Get Content & Permissions Free
Lymphoma Patients at Higher Risk of Death When Diagnosed With COVID-19 Froelich, Warren Froelich, Warren Less Oncology Times. 43(7):35, April 5, 2021. Favorites PDF Get Content & Permissions Free
Novel Agents Show Promise in Diffuse Large B-Cell Lymphoma Fuerst, Mark L. Fuerst, Mark L. Less Oncology Times. 43(7):32, April 5, 2021. Favorites PDF Get Content & Permissions Free
CARs Are the Ride of the Future for Curing DLBCL Fuerst, Mark L. Fuerst, Mark L. Less Oncology Times. 43(7):31, April 5, 2021. Favorites PDF Get Content & Permissions Free
Burkitt Lymphoma: An International Prognostic Index Evens, Andrew M. Evens, Andrew M. Less Oncology Times. 43(7):1,10-11, April 5, 2021. Favorites PDF Get Content & Permissions Free
Advances in the Treatment of Patients With R/R Follicular Lymphoma Kumar Das, Dibash Kumar Das, Dibash Less Oncology Times. 43(6):1,11, March 20, 2021. Favorites PDF Get Content & Permissions Free
Scientists Create On-Off Switches to Control CAR T-Cell Activity Less Oncology Times. 43(4):1,12, February 20, 2021. Favorites PDF Get Content & Permissions Free
The Discovery of a Potent Weapon Against Lymphomas Less Oncology Times. 43(3):28, February 5, 2021. Favorites PDF Get Content & Permissions Free
3 QUESTIONS ON... How to Better Manage Late Effects for Survivors of Hodgkin Lymphoma: With Andrew Evens, DO, MSc, of Rutgers Cancer Institute of New Jersey DiGiulio, Sarah DiGiulio, Sarah Less Oncology Times. 42(24):98, December 20, 2020. Favorites PDF Get Content & Permissions Free
A New Strategy in Treating Patients With CAR T-Cell Therapy Jenks, Susan Jenks, Susan Less Oncology Times. 42(24):34, December 20, 2020. Favorites PDF Get Content & Permissions Free
Potential New Standard for High-Risk B-Cell Non-Hodgkin Lymphoma Kumar Das, Dibash Kumar Das, Dibash Less Oncology Times. 42(24):1,3,14, December 20, 2020. Favorites PDF Get Content & Permissions Free
Study Shows Many Non-Hodgkin Lymphoma Patients Can Skip Radiation Less Oncology Times. 42(21):26, November 5, 2020. Favorites PDF Get Content & Permissions Free
Cell Therapy Ascends: New Hope for Combating Mantle Cell Lymphoma Neff Newitt, Valerie Neff Newitt, Valerie Less Oncology Times. 42(20):1,14,15,38, October 20, 2020. Favorites PDF Get Content & Permissions Free
Overcoming the Challenge of Cytokine Release Syndrome in CAR T-Cell Therapy Bennett, Christina Bennett, Christina Less Oncology Times. 42(20):1,10, October 20, 2020. Favorites PDF Get Content & Permissions Free
Examining Gene Mutations in Mantle Cell Lymphoma Patients Froelich, Warren Froelich, Warren Less Oncology Times. 42(19):34, October 5, 2020. Favorites PDF Get Content & Permissions Free
Identifying Disparities in Adolescent & Young Adult Lymphoma Survivors Froelich, Warren Froelich, Warren Less Oncology Times. 42(19):33,37, October 5, 2020. Favorites PDF Get Content & Permissions Free
New Scoring System Helps Stratify Mantle Cell Lymphoma Patients Fuerst, Mark L. Fuerst, Mark L. Less Oncology Times. 42(18):22, September 20, 2020. Favorites PDF Get Content & Permissions Free
Lymphoma Takes a Different Route to Development Less Oncology Times. 42(9):1,7, May 5, 2020. Favorites PDF Get Content & Permissions Free
CD19 CAR NK-Cell Therapy in Leukemia & Lymphoma Less Oncology Times. 42(5):35, March 5, 2020. Favorites PDF Get Content & Permissions Free
Novel Targeted Therapies for Blastic Plasmacytoid Dendritic Cell Neoplasm Pemmaraju, Naveen Pemmaraju, Naveen Less Oncology Times. 42(1):1,11-12, January 5, 2020. Favorites PDF Get Content & Permissions Free
Identifying Mechanisms of Resistance to ABT-199 in Lymphomas May, Brandon May, Brandon Less Oncology Times. 41(15):9, August 5, 2019. Favorites PDF Get Content & Permissions Free
A New Approach to Spur the Immune System to Attack Lymphoma Less Oncology Times. 41(15):1,7, August 5, 2019. Favorites PDF Get Content & Permissions Free
Recent Developments in the Treatment of Mantle Cell Lymphoma Simoneaux, Richard Simoneaux, Richard Less Oncology Times. 41(15):1,5-6, August 5, 2019. Favorites PDF Get Content & Permissions Free
Why Advances in Immunotherapy Mean the Golden Age of Oncology Landau, Daniel Landau, Daniel Less Oncology Times. 41(13):24,32, July 5, 2019. Favorites PDF Get Content & Permissions Free
Recent Developments in the Treatment of Follicular Lymphoma Simoneaux, Richard Simoneaux, Richard Less Oncology Times. 41(11):8-10, June 5, 2019. Favorites PDF Get Content & Permissions Free CME Test
Why Lymphoma Patients Become Resistant to Specific Therapy Less Oncology Times. 41(11):1,12, June 5, 2019. Favorites PDF Get Content & Permissions Free
Umbralisib Shows Encouraging Potential in Marginal Zone Lymphoma Samson, Kurt Samson, Kurt Less Oncology Times. 41(10):38, May 20, 2019. Favorites PDF Get Content & Permissions Free
Gene Sequencing & the Follicular Lymphoma Tumor Microenvironment Hepp, Rebecca Hepp, Rebecca Less Oncology Times. 41(6):1,4, March 20, 2019. Favorites PDF Get Content & Permissions Free
Characterizing the Mechanism of Action of CAR T Cells Less Oncology Times. 41(5):1,5, March 5, 2019. Favorites PDF Get Content & Permissions Free
Novel Therapies to Increase Durable Remission Rates for T-Cell Lymphoma Neff Newitt, Valerie Neff Newitt, Valerie Less Oncology Times. 40(23):1,6-7, December 5, 2018. Favorites PDF Get Content & Permissions Free
Prevalent Epigenetic Modifier Mutations Found in Follicular Lymphoma Simoneaux, Richard Simoneaux, Richard Less Oncology Times. 40(22):1,8-9, November 20, 2018. Favorites PDF Get Content & Permissions Free
Genomic Analysis Unravels the Many Complexities of DLBCL Less Oncology Times. 40(19):39, October 5, 2018. Favorites PDF Get Content & Permissions Free
Utilizing Acalabrutinib Alone or in Combination for Follicular Lymphoma Nalley, Catlin Nalley, Catlin Less Oncology Times. 40(19):38, October 5, 2018. Favorites PDF Get Content & Permissions Free
Blood Test Predicts Lymphoma Therapy Success Within Days Less Oncology Times. 40(18):1,4-5, September 20, 2018. Favorites PDF Get Content & Permissions Free
Applying Genomics to Leukemias & Lymphomas Parikh, Ankur R. Parikh, Ankur R. Less Oncology Times. 40(17):1,2,3,4,8, September 5, 2018. Favorites PDF Get Content & Permissions Free
Evaluating CAR-T Therapy in Patients With Refractory B-Cell Lymphomas Simoneaux, Richard Simoneaux, Richard Less Oncology Times. 40(15):1,8-9, August 5, 2018. Favorites PDF Get Content & Permissions Free CME Test
Advances in the Systemic Management of Follicular Lymphoma Tan, Alan Tan, Alan Less Oncology Times. 40(14):1,5,6,19, July 20, 2018. Favorites PDF Get Content & Permissions Free
The Ibrutinib-Venetoclax Combination in Mantle Cell Lymphoma Simoneaux, Richard Simoneaux, Richard Less Oncology Times. 40(13):1,9,13, July 5, 2018. Favorites PDF Get Content & Permissions Free
Genomic Analysis of Diffuse Large B-Cell Lymphoma Less Oncology Times. 40(10):8, May 20, 2018. Favorites PDF Get Content & Permissions Free
‘Excellence in Oncology’ Winner: Earning Praise for CAR T-Cell Therapy Holt, Chuck Holt, Chuck Less Oncology Times. 40(10):1,9-10, May 20, 2018. Favorites PDF Get Content & Permissions Free
NCI Study Revises Molecular Classification for Most Common Lymphoma Less Oncology Times. 40(9):1-2, May 5, 2018. Favorites PDF Get Content & Permissions Free
A+AVD vs. ABVD in Hodgkin Lymphoma: A Comparison of Toxicities Greenwell, I. Brian; Cohen, Jonathon B. Greenwell, I. Brian; Cohen, Jonathon B. Less Oncology Times. 40(6):1,5,8, March 20, 2018. Favorites PDF Get Content & Permissions Free
Mogamulizumab Outperforms Vorinostat in Previously Treated CTCL Patients Fuerst, Mark L. Fuerst, Mark L. Less Oncology Times. 40(3):36, February 5, 2018. Favorites PDF Get Content & Permissions Free
CAR T-Cell Therapy Induces Long-Lasting Responses in Refractory NHL Fuerst, Mark L. Fuerst, Mark L. Less Oncology Times. 40(3):33, February 5, 2018. Favorites PDF Get Content & Permissions Free
CAR T-Cell Therapy Induces Sustained Responses in DLBCL Fuerst, Mark L. Fuerst, Mark L. Less Oncology Times. 40(3):29, February 5, 2018. Favorites PDF Get Content & Permissions Free
Immunotherapy Shows Promise in Treatment of Hodgkin Lymphoma Nalley, Catlin Nalley, Catlin Less Oncology Times. 40(2):1,12, January 20, 2018. Favorites PDF Get Content & Permissions Free
Genetic Link Between the Immune System & Lymphoma Less Oncology Times. 39(24):1,9, December 25, 2017. Favorites PDF Get Content & Permissions Free
3 Questions on...Why Bone Marrow Biopsies May Not Be Needed for Patients in Clinical Trials: With Sarah Rutherford, MD, in the Division of Hematology & Medical Oncology at Weill Cornell Medicine DiGiulio, Sarah DiGiulio, Sarah Less Oncology Times. 39(21):40, November 10, 2017. Favorites PDF Get Content & Permissions Free
Triplet Therapy Safe & Highly Active in Patients With Advanced Disease Less Oncology Times. 39(21):37, November 10, 2017. Favorites PDF Get Content & Permissions Free
Phase II Study Suggests Tazemetostat Beneficial in Relapsed/Refractory Less Oncology Times. 39(21):35-36, November 10, 2017. Favorites PDF Get Content & Permissions Free
Study Shows Immunologic Doublet Active Among Relapsed Patients Nalley, Catlin Nalley, Catlin Less Oncology Times. 39(21):31-32, November 10, 2017. Favorites PDF Get Content & Permissions Free
Researchers Investigate Markers That May Help Prognostication Lindsey, Heather Lindsey, Heather Less Oncology Times. 39(21):29-30, November 10, 2017. Favorites PDF Get Content & Permissions Free
Phase II Trial Shows Efficacy of Potential Oral Therapy Green, Chuck Green, Chuck Less Oncology Times. 39(21):27-28, November 10, 2017. Favorites PDF Get Content & Permissions Free
PI3K Inhibitor Shows Promise for Patients With Relapsed/Refractory Disease Nalley, Catlin Nalley, Catlin Less Oncology Times. 39(21):25-26, November 10, 2017. Favorites PDF Get Content & Permissions Free
Many Patients Not Receiving Treatment in Rituximab Era Lindsey, Heather Lindsey, Heather Less Oncology Times. 39(21):23-24, November 10, 2017. Favorites PDF Get Content & Permissions Free
Discovery of Specific Gene Could Lead to New Treatment Options Green, Chuck Green, Chuck Less Oncology Times. 39(21):21-22, November 10, 2017. Favorites PDF Get Content & Permissions Free
MAGNIFY Trial Shows Durability of Lenalidomide & Rituximab May, Brandon May, Brandon Less Oncology Times. 39(21):17-18, November 10, 2017. Favorites PDF Get Content & Permissions Free
Circulating Cell-Free DNA May Enhance TMTV Prognostication Lindsey, Heather Lindsey, Heather Less Oncology Times. 39(21):15-16, November 10, 2017. Favorites PDF Get Content & Permissions Free
Autologous HSCT Confers Greater Survival Benefit Over Allogeneic Option May, Brandon May, Brandon Less Oncology Times. 39(21):13-14, November 10, 2017. Favorites PDF Get Content & Permissions Free
Idelalisib Effective Among Patients With Early Progression Nalley, Catlin Nalley, Catlin Less Oncology Times. 39(21):11-12, November 10, 2017. Favorites PDF Get Content & Permissions Free
Follicular Lymphoma Treatment Strategies Continue to Evolve, Unmet Needs Remain Neff Newitt, Valerie Neff Newitt, Valerie Less Oncology Times. 39(21):2-10, November 10, 2017. Favorites PDF Get Content & Permissions Free
Rituximab/Hyaluronidase (Rituxan Hycela™) Melaragno, Adam Melaragno, Adam Less Oncology Times. 39(20):18, October 25, 2017. Favorites PDF Get Content & Permissions Free
Obinutuzumab Granted Priority Review for Follicular Lymphoma Less Oncology Times. 39(18):49, September 25, 2017. Favorites PDF Get Content & Permissions Free
Longer Nivolumab Response Reported in Hodgkin Lymphoma Patients Samson, Kurt Samson, Kurt Less Oncology Times. 39(15):1,14,15,18, August 10, 2017. Favorites PDF Get Content & Permissions Free
Copanlisib Given Priority Review Designation for Follicular Lymphoma Less Oncology Times. 39(12):33, June 25, 2017. Favorites PDF Get Content & Permissions Free
Evolving Treatment Strategies for Mantle Cell Lymphoma Fakhri, Bita; Kahl, Brad Fakhri, Bita; Kahl, Brad Less Oncology Times. 39(11):1,16,27, June 10, 2017. Favorites PDF Get Content & Permissions Free
eFT508 Granted Orphan Designation for B-Cell Lymphoma Less Oncology Times. 39(7):10, April 10, 2017. Favorites PDF Get Content & Permissions Free
Hodgkin Lymphoma Survivors at High Risk of Second Cancers Less Oncology Times. 39(7):1,14, April 10, 2017. Favorites PDF Get Content & Permissions Free
Ibrutinib Approved for Marginal Zone Lymphoma Patients Less Oncology Times. 39(4):19, February 25, 2017. Favorites PDF Get Content & Permissions Free
Patients With Advanced Lymphoma in Remission After T-Cell Therapy Less Oncology Times. 38(19):1,12, October 10, 2016. Favorites PDF Get Content & Permissions Free
Brentuximab Vedotin May Cure Some Hodgkin Lymphoma Patients Fuerst, Mark L. Fuerst, Mark L. Less Oncology Times. 38(17):1,10, September 10, 2016. Favorites PDF Get Content & Permissions Free
Stem Cell Transplantation for HIV-Associated Lymphoma Less Oncology Times. 38(15):1,12, August 10, 2016. Favorites PDF Get Content & Permissions Free
Novel Drug Development in CLL & HNL Carlson, Robert H. Carlson, Robert H. Less Oncology Times. 38(14):1,11,13, July 25, 2016. Favorites PDF Get Content & Permissions Free
FDA Approves Bendeka (Bendamustine Hydrochloride) Injection for CLL and NHL Less Oncology Times. 38(3):33, February 10, 2016. Favorites PDF Get Content & Permissions Free
Protein Associated with Myeloma & DLBCL also Found to Play Role in CTCL DiGiulio, Sarah DiGiulio, Sarah Less Oncology Times. 38(3):41, February 10, 2016. Favorites PDF Get Content & Permissions Free
Hodgkin Lymphoma Survivors Face Long-term Elevated Risk of Cardiovascular Disease Kim, Meeri N. Kim, Meeri N. Less Oncology Times. 38(3):1,11-11, February 10, 2016. Favorites PDF Get Content & Permissions Free
Mantle Cell Lymphoma: Follow-Up Confirms Ibrutinib's Benefits in Relapsed/Refractory Disease Lindsey, Heather Lindsey, Heather Less Oncology Times. 37(18):24-25, September 25, 2015. Favorites PDF Get Content & Permissions Free
The Lymphoma-Melanoma Connection Fuerst, Mark L. Fuerst, Mark L. Less Oncology Times. 37(18):1,26-28, September 25, 2015. Favorites PDF Get Content & Permissions Free
CTCL: Early Results Promising for Topical Gel Less Oncology Times. 37(17):35, September 10, 2015. Favorites PDF Get Content & Permissions Free
FDA Approves Adcetris for Another HL Indication Less Oncology Times. 37(17):4-5, September 10, 2015. Favorites PDF Get Content & Permissions Free
Next-Gen Genomics Hit Lymphoma Diagnosis, Therapy Fuerst, Mark L. Fuerst, Mark L. Less Oncology Times. 37(15):1,19-20, August 10, 2015. Favorites PDF Get Content & Permissions Free
WHO Lymphoma Classification Update in Progress, but Is It ‘Too Complicated’? Fuerst, Mark L. Fuerst, Mark L. Less Oncology Times. 37(14):26-27, July 25, 2015. Favorites PDF Get Content & Permissions Free
NHL: Inotuzumab Ozogamicin Shows Activity Both Alone & Combined with Rituximab Fuerst, Mark Fuerst, Mark Less Oncology Times. 33(5):52-53, March 10, 2011. Favorites PDF Get Content & Permissions Free
ASH ANNUAL MEETING: Brentuximab Shows High Response Rates in Relapsed Refractory Lymphomas Carlson, Robert H. Carlson, Robert H. Less Oncology Times. 33(2):28,30-32, January 25, 2011. Favorites PDF Get Content & Permissions Free
ASH Plenary Study: For Follicular Lymphoma, Use of Rituximab in Asymptomatic Patients Prolongs Time to Initial Treatment—But Not Survival Carlson, Robert H. Carlson, Robert H. Less Oncology Times. 33(2):26-28, January 25, 2011. Favorites PDF Get Content & Permissions Free
BAFF Mutation Also Found in NHL Less Oncology Times. 32(24):16, December 25, 2010. Favorites PDF Get Content & Permissions Free
Immunoconjugates: Rapidly Changing & Promising Field Carlson, Robert H. Carlson, Robert H. Less Oncology Times. 32(24):44-46, December 25, 2010. Favorites PDF Get Content & Permissions Free
Follicular Lymphoma: Time to Reevaluate ‘Watch and Wait’? Carlson, Robert H. Carlson, Robert H. Less Oncology Times. 32(22):22, November 25, 2010. Favorites PDF Get Content & Permissions Free
Documented: Chronic Health Conditions Remain a Problem for Hematopoietic Cell Transplant Patients Lindsey, Heather Lindsey, Heather Less Oncology Times. 32(21):18-20, November 10, 2010. Favorites PDF Get Content & Permissions Free
NCCN Publishes Guidelines for Cancer Patients Less Oncology Times. 32(19):19, October 10, 2010. Favorites PDF Get Content & Permissions Free
